AEROSOL FLUOROQUINOLONE FORMULATIONS FOR IMPROVED PHARMACOKINETICS

The present invention relates to the field of antimicrobial agents. In particular, the present invention relates to the use of aerosolized fluoroquinolones formulated with divalent or trivalent cations and having improved pulmonary availability for the treatment and management of bacterial infection...

Full description

Saved in:
Bibliographic Details
Main Authors GRIFFITH, David C, SURBER, Mark W, RODNY, Olga, DUDLEY, Michael N, BOSTIAN, Keith A
Format Patent
LanguageEnglish
Published 29.04.2021
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention relates to the field of antimicrobial agents. In particular, the present invention relates to the use of aerosolized fluoroquinolones formulated with divalent or trivalent cations and having improved pulmonary availability for the treatment and management of bacterial infections of the lung and upper respiratory tract.
Bibliography:Application Number: US202016903132